Literature DB >> 31202821

An Activation Likelihood Estimate Meta-analysis of Thalamocortical Dysconnectivity in Psychosis.

Ian S Ramsay1.   

Abstract

BACKGROUND: Thalamocortical dysconnectivity is hypothesized to underlie the pathophysiology of psychotic disorders, including schizophrenia and bipolar disorder, and individuals at clinical high risk. Numerous studies have examined connectivity networks seeding from the thalamus during rest, revealing a pattern of thalamo-fronto-cerebellar hypoconnectivity and thalamosensory hyperconnectivity. However, given variability in these networks, as well as their relationships with clinical and cognitive symptoms, thalamocortical connectivity's status as a biomarker and treatment target for psychotic disorders remains unclear.
METHODS: A literature search was performed to identify thalamic seed-based connectivity studies conducted in patients with psychotic disorders. Activation likelihood estimate analysis examined the reported coordinates for hypoconnectivity (healthy control participants > patients with psychosis) and hyperconnectivity (patients with psychosis > healthy control participants). The relationship between hypoconnectivity and hyperconnectivity, as well as their relationships with clinical and cognitive measures, was meta-analyzed.
RESULTS: Each activation likelihood estimate included 20 experiments (from 17 publications). Thalamocortical hypoconnectivity was observed in middle frontal, cingulate, and thalamic regions, while hyperconnectivity was observed in motor, somatosensory, temporal, occipital, and insular cortical regions. Meta-analysis of the studies reporting correlations between hypo- and hyperconnectivity showed a strong negative relationship. Meta-analysis of studies reporting correlations between hyperconnectivity and symptoms showed small but significant positive relationships.
CONCLUSIONS: Activation likelihood estimates of thalamocortical hypoconnectivity revealed a network of prefrontal and thalamic regions, while hyperconnections identified sensory areas. The strong negative relationship between these thalamocortical deflections suggests that they arrive from a common mechanism and may account for aspects of psychosis. These findings identify reliable thalamocortical networks that may guide future studies and serve as crucial treatment targets for psychotic disorders.
Copyright © 2019 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Activation likelihood estimate; Connectivity; Psychosis; Schizophrenia; Thalamocortical; Thalamus

Mesh:

Year:  2019        PMID: 31202821     DOI: 10.1016/j.bpsc.2019.04.007

Source DB:  PubMed          Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging        ISSN: 2451-9022


  10 in total

1.  Increased global cognition correlates with increased thalamo-temporal connectivity in response to targeted cognitive training for recent onset schizophrenia.

Authors:  Ian S Ramsay; Brian J Roach; Susanna Fryer; Melissa Fisher; Rachel Loewy; Judith M Ford; Sophia Vinogradov; Daniel H Mathalon
Journal:  Schizophr Res       Date:  2020-01-29       Impact factor: 4.939

2.  Neural basis of the visual working memory deficit in schizophrenia: Merging evidence from fMRI and EEG.

Authors:  Molly A Erickson; Britta Hahn; John E Kiat; Luz Maria Alliende; Steven J Luck; James M Gold
Journal:  Schizophr Res       Date:  2021-08-13       Impact factor: 4.662

3.  Frontotemporal thalamic connectivity in schizophrenia and schizotypal personality disorder.

Authors:  Philip R Szeszko; Suril Gohel; Daniel H Vaccaro; King-Wai Chu; Cheuk Y Tang; Kim E Goldstein; Antonia S New; Larry J Siever; Margaret McClure; M Mercedes Perez-Rodriguez; M Mehmet Haznedar; William Byne; Erin A Hazlett
Journal:  Psychiatry Res Neuroimaging       Date:  2022-02-19       Impact factor: 2.493

4.  Thalamic Nuclei Volumes in Psychotic Disorders and in Youths With Psychosis Spectrum Symptoms.

Authors:  Anna S Huang; Baxter P Rogers; Julia M Sheffield; Maria E Jalbrzikowski; Alan Anticevic; Jennifer Urbano Blackford; Stephan Heckers; Neil D Woodward
Journal:  Am J Psychiatry       Date:  2020-09-11       Impact factor: 18.112

5.  Resting State Functional Connectivity of Brain With Electroconvulsive Therapy in Depression: Meta-Analysis to Understand Its Mechanisms.

Authors:  Preeti Sinha; Himanshu Joshi; Dhruva Ithal
Journal:  Front Hum Neurosci       Date:  2021-01-21       Impact factor: 3.169

6.  Shared and specific patterns of structural and functional thalamo-frontal disturbances in manic and euthymic pediatric bipolar disorder.

Authors:  Yi-Bing Guo; Wei-Jia Gao; Zhi-Liang Long; Wei-Fang Cao; Dong Cui; Yong-Xin Guo; Qing Jiao; Jian-Feng Qiu; Lin-Yan Su; Guang-Ming Lu
Journal:  Brain Imaging Behav       Date:  2021-08-25       Impact factor: 3.978

7.  Validation of ketamine as a pharmacological model of thalamic dysconnectivity across the illness course of schizophrenia.

Authors:  Samantha V Abram; Brian J Roach; Susanna L Fryer; Vince D Calhoun; Adrian Preda; Theo G M van Erp; Juan R Bustillo; Kelvin O Lim; Rachel L Loewy; Barbara K Stuart; John H Krystal; Judith M Ford; Daniel H Mathalon
Journal:  Mol Psychiatry       Date:  2022-04-14       Impact factor: 13.437

Review 8.  The Basal Forebrain Cholinergic Nuclei and Their Relevance to Schizophrenia and Other Psychotic Disorders.

Authors:  Sofia Eickhoff; Leon Franzen; Alexandra Korda; Helena Rogg; Valerie-Noelle Trulley; Stefan Borgwardt; Mihai Avram
Journal:  Front Psychiatry       Date:  2022-07-06       Impact factor: 5.435

9.  Altered thalamocortical structural connectivity in persons with schizophrenia and healthy siblings.

Authors:  Beier Yao; Sebastiaan F W Neggers; René S Kahn; Katharine N Thakkar
Journal:  Neuroimage Clin       Date:  2020-07-31       Impact factor: 4.891

Review 10.  Selective Review of Neuroimaging Findings in Youth at Clinical High Risk for Psychosis: On the Path to Biomarkers for Conversion.

Authors:  Justin K Ellis; Elaine F Walker; David R Goldsmith
Journal:  Front Psychiatry       Date:  2020-09-23       Impact factor: 4.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.